Strides Pharma buys four approved ANDAs from Nostrum Labs for over Rs 17 crore Ruchika Sharma30 April 2025 3:28 PM ISTBengaluru: Strides Pharma Inc., a Step-down wholly-owned subsidiary of Strides Pharma Science Limited in the US, has acquired four...
Strides Pharma Recalls Testosterone Gel In US Market Farhat Nasim5 April 2025 1:27 PM ISTThe Chestnut Ridge-based drugmaker, a part of Bengaluru-based Strides Pharma Science, is recalling the affected lot due to the 'Presence of Benzene'.
Strides Pharma Secures NCLT Approval for OneSource, India's First Specialty Pharma CDMO Farhat Nasim21 Nov 2024 1:56 PM ISTMumbai: Strides Pharma Science Limited, on Tuesday, announced that the National Company Law Tribunal (NCLT), Mumbai Bench, has approved its Scheme of...
Strides Pharma Posts Record Q2 Growth with Rs 12,011 Million Revenue, Highest Ever US Sales MD Bureau25 Oct 2024 3:03 PM ISTBengaluru: Strides Pharma Science Ltd. reported robust Q2FY25 financial results, ending September 30, 2024, with consolidated revenues at Rs 12,011...
Strides Pharma arm raises Rs 801 crore in pre-listing round MD Bureau16 Oct 2024 4:57 PM ISTOneSource Specialty Pharma, the CDMO arm of the company, has received confirmed capital infusion commitment from investors
Strides Pharma Q1 results: Net profit at Rs 84 crore vs net loss of Rs 29.5 crore a year ago Ruchika Sharma30 July 2024 4:24 PM ISTBangalore: Strides Pharma Science has announced a profit after tax (PAT) from continuing operations of Rs 84 crore for the first quarter ended...
Strides Pharma Science Singapore arm gets USFDA nod for Sevelamer Carbonate for Oral Suspension Ruchika Sharma11 Sept 2023 11:39 AM ISTSevelamer Carbonate for Oral Suspension is a medication used to manage elevated levels of phosphate in the blood of patients with chronic kidney...
Strides Singapore arm bags USFDA nod for Mycophenolate Mofetil for Oral Suspension Ruchika Sharma31 Aug 2023 1:30 PM ISTMycophenolate Mofetil for Oral Suspension belongs to a group of medicines called immunosuppressants.
Strides Pharma Science biologics arm to divest Unit 3 multi modal facility to Syngene International for Rs 702 crore Ruchika Sharma5 July 2023 12:30 PM ISTBengaluru: Stelis Biopharma Limited, an emerging biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and the biologics arm...
Strides, Orbicular ink pact to develop range of nasal sprays Ruchika Sharma3 May 2023 11:30 AM ISTThe partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m.
Strides Pharma Science Bangalore facility gets USFDA inspection closure Ruchika Sharma24 Feb 2023 11:19 AM ISTThe flagship facility in Bangalore is the largest manufacturing facility for the company, with the capability to produce finished dosage formulation...
Strides Pharma Science Singapore arm secures USFDA okay for Potassium Chloride Oral Solution Ruchika Sharma18 Nov 2022 3:30 PM ISTPotassium Chloride Oral Solution is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for...
